Efficacy and safety of larotrectinib as first-line treatment for patients (pts) with TRK fusion cancer: An updated analysis Meeting Abstract
| Authors: | Hong, D. S.; Xu, R. H.; Shen, L.; Dierselhuis, M. P.; Orbach, D.; McDermott, R. S.; Italiano, A.; Tahara, M.; Bernard-Gauthier, V.; Neu, N.; Mussi, C. E.; De La Cuesta, E. A.; Laetsch, T.; Drilon, A. E. |
| Abstract Title: | Efficacy and safety of larotrectinib as first-line treatment for patients (pts) with TRK fusion cancer: An updated analysis |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S501 |
| End Page: | S502 |
| Language: | English |
| ACCESSION: | WOS:001326612900622 |
| DOI: | 10.1016/j.annonc.2024.08.695 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 628P -- Source: Wos |
